Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Yael Ratner"'
Autor:
Yael Ratner, Michael S. Ritsner
Publikováno v:
Acta Scientific Neurology. :39-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07ec72e25199cdef45de5affd438333c
https://doi.org/10.31080/asne.2021.04.0449
https://doi.org/10.31080/asne.2021.04.0449
Publikováno v:
Psychiatry Research. 270:503-509
Background Patients’ perception of psychiatric healthcare is a critical indicator in measuring service quality. The aim of the study was to determine patient's level of satisfaction with the quality of health care delivered at the inpatient departm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3cedeb0aa41e2db1e14ebee4694457f
https://doi.org/10.1016/j.psychres.2018.10.027
https://doi.org/10.1016/j.psychres.2018.10.027
Autor:
Michael S. Ritsner, Yael Ratner
Publikováno v:
The Journal of nervous and mental disease. 207(1)
This study sought to evaluate predischarge anhedonia level and its predictors in 125 inpatients with schizophrenia and schizoaffective disorders. Consecutively admitted inpatients were assessed before discharge from the hospital using the Specific Lo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff6fcb13cb8d73f2351ed8b30ccc6b38
https://pubmed.ncbi.nlm.nih.gov/30575703
https://pubmed.ncbi.nlm.nih.gov/30575703
Publikováno v:
Psychiatry research. 270
Although social hedonic capacity is often assessed in clinical settings, its operational definitions have not been evaluated for concurrent validity. One hundred and twenty-five patients with schizophrenia and schizoaffective disorder were classified
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abcd64998c4db36f9e0933eaef8e8140
https://pubmed.ncbi.nlm.nih.gov/30551345
https://pubmed.ncbi.nlm.nih.gov/30551345
Autor:
Michael S. Ritsner, Michael Ermiyev, Diane C. Gooding, Nina Mendyk, Yael Ratner, Herman Farkash
Publikováno v:
Schizophrenia Bulletin
Background Although many people with schizophrenia-spectrum disorders report high levels of social anhedonia, it is not clear what differentiates those patients who self-report social anhedonia from those who do not. Moreover, the extent to which the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96e483883d2e54e90c94dcd95c927b24
http://europepmc.org/articles/PMC5888171
http://europepmc.org/articles/PMC5888171
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:1401-1409
Objective This is a first report from a long-term study aimed to evaluate efficacy, safety, tolerability, cognitive functioning, and quality of life outcomes during ziprasidone treatment of chronic schizophrenia patients in the “real-world”. Meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::091407171ecb5bbdd30952a3e41229d1
https://doi.org/10.1016/j.pnpbp.2007.06.008
https://doi.org/10.1016/j.pnpbp.2007.06.008
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 31:1470-1477
Objective Health related quality of life (HRQL) has become an important outcome measure in the treatment of psychiatric disorders. This long-term observational study examined ziprasidone-induced improvement in satisfaction with HRQL in schizophrenia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58325cc9057c462dbf4945f5b78f9905
https://doi.org/10.1016/j.pnpbp.2007.06.029
https://doi.org/10.1016/j.pnpbp.2007.06.029
Publikováno v:
Clinical schizophreniarelated psychoses. 12(1)
Pregnenolone (PREG) and L-theanine (LT) have shown ameliorative effects on various schizophrenia symptoms. This is the first study to evaluate the efficacy and safety of augmentation of antipsychotic treatment among patients with chronic schizophreni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1e2f7b5310a52781e962f015693a3c1
https://pubmed.ncbi.nlm.nih.gov/26218236
https://pubmed.ncbi.nlm.nih.gov/26218236
Publikováno v:
Journal of Clinical Psychopharmacology. 26:495-499
Background: Dehydroepiandrosterone (DHEA) augmentation has been reported, in a preliminary fashion, to be useful in the management of schizophrenia symptoms and side effects. In this study, the intention was to investigate the efficacy and safety of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2264de7265e91b240434f0ea021541a
https://doi.org/10.1097/01.jcp.0000237942.50270.35
https://doi.org/10.1097/01.jcp.0000237942.50270.35
Autor:
Michael S. Ritsner, Yael Ratner
Publikováno v:
Journal of Nervous & Mental Disease. 194:261-267
This prospective study aimed to define the long-term changes in coping strategies used by schizophrenia patients and their relation to clinical and psychosocial factors. The Coping Inventory for Stressful Situations, psychiatric scales, and self-repo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d11197103b42cb0d6432c0072bcb61
https://doi.org/10.1097/01.nmd.0000207361.81947.52
https://doi.org/10.1097/01.nmd.0000207361.81947.52